CVE-2026-31913

Name: CVE-2026-31913
Creator: NVD / NIST
Published: 2026-03-25T17:16:58.517+00:00
License: https://creativecommons.org/publicdomain/zero/1.0/

HIGHCVSS 8.6/10EPSS 0.37%

Last modified Jun 17, 2026

CVE-2026-31913 is a high-severity vulnerability rated 8.6/10 on the CVSS scale. Improper Limitation of a Pathname to a Restricted Directory ('Path Traversal') vulnerability in Whitebox-Studio Scape scape allows Path Traversal.This issue affects Scape: from n/a through < 1.5.16.. EPSS estimates a 0.37% chance of exploitation in the next 30 days.

Description

Improper Limitation of a Pathname to a Restricted Directory ('Path Traversal') vulnerability in Whitebox-Studio Scape scape allows Path Traversal.This issue affects Scape: from n/a through < 1.5.16.

Metrics

CVSS 3.1

8.6/10

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:C/C:N/I:N/A:H

EPSS Probability

0.37%

29.0th percentile

Probability of exploitation in the next 30 days. Learn more

Weakness Enumeration

CWE-22

References

https://patchstack.com/database/Wordpress/Theme/scape/vulnerability/wordpress-scape-theme-1-5-16-arbitrary-file-deletion-vulnerability?_s_id=cve

Timeline

Published: Mar 25, 2026
Last Modified: Jun 17, 2026
Status: Deferred

Frequently Asked Questions

What is CVE-2026-31913?

Improper Limitation of a Pathname to a Restricted Directory ('Path Traversal') vulnerability in Whitebox-Studio Scape scape allows Path Traversal.This issue affects Scape: from n/a through < 1.5.16.

How severe is CVE-2026-31913?

CVE-2026-31913 has a CVSS score of 8.6/10 (HIGH severity). The EPSS model estimates a 0.37% probability of exploitation in the next 30 days.

How do I fix CVE-2026-31913?

Check the vendor references and advisories linked above for patched versions and mitigation guidance. You can also run a Strix scan to test if your systems are affected.

Are you affected by CVE-2026-31913?

Run a free Strix scan to check your systems for this vulnerability.

Scan your code now

Source: NVD / NIST